GoodRx Holdings, Inc.

NASDAQ:GDRX

Medical - Healthcare Information Services

Healthcare
$3.36 +1.72%

+$0.05 today

Market cap
$1.15B
Beta
1.61
P/E (TTM)
44.0
EPS (TTM)
$0.06
52W Low $1.77High $5.81

Volume 0.66M

Average 1.61M

GDRX Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

GoodRx Holdings, Inc.NASDAQ: GDRX

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 78.4%

Gross margin was 78.4% in Q1 FY2026, down 15.0 pp from a year earlier. On a trailing-twelve-month basis it was 86.6%, down 7.3 pp year over year. Over 3 fiscal years it widened by 1.3 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
78.4%-12.7 pp QoQ
Last fiscal yearDec 2025
92.8%-1.1 pp YoY
LTMMar 2026
86.6%-7.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-15.0 pp——
1 year-1.1 pp——
3 years+1.3 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
92.8%
Year-over-year change
-1.1pp

Gross Margin vs competitors

How GDRX compares with its peers on the latest reported figures

  • GDRX's LTM Mar 2026 gross margin of 86.6% is the highest of the 4 companies compared; the peer median is 65.6%.
  • Its year-over-year change of -7.3 pp is the lowest of 4, against a peer median of -2.1 pp.
  • Over three fiscal years its change of +1.3 pp compares with a peer median of +0.4 pp.
GDRX Competitors Peer median
Gross Margin for GDRX and competitors
Company Period LTM level YoY 3-year change
GDRXGoodRx Holdings, Inc.LTM Mar 202686.6% -7.3 pp+1.3 pp
LFMDLifeMD, Inc.LTM Mar 202685.9% -2.1 pp-4.6 pp
TDOCTeladoc Health, Inc.LTM Mar 202665.6% -4.9 pp+0.4 pp
AMWLAmerican Well CorporationLTM Mar 202649.7% +5.4 pp+11.2 pp
Peer median (excluding GDRX) 65.6%-2.1 pp+0.4 pp

Competitors are the stored peer set for GDRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue745.42M766.55M750.27M792.32M796.85M
Cost of Revenue46.72M65.08M66.93M48.22M57.6M
Gross Profit698.71M701.48M683.34M744.11M739.26M
Gross Margin93.7%91.5%91.1%93.9%92.8%
Research & Development125.86M143.14M135.84M123.75M121.03M
Selling, General & Admin524.9M502.42M466.84M484.98M445.52M
Operating Expenses685.3M699.74M710.35M678.26M651.76M
Depreciation & Amortization34.54M54.18M107.67M69.54M85.22M
EBITDA48M65.19M108.82M153.92M184.36M
EBITDA Margin6.4%8.5%14.5%19.4%23.1%
Operating Income13.41M1.74M(27.01M)65.85M87.49M
Operating Margin1.8%0.2%-3.6%8.3%11.0%
Interest Income59K9.27M32.17M23.27M10.93M
Interest Expense23.64M34.24M56.73M52.92M42.61M
Other Income / Expenses(23.58M)(24.97M)(28.57M)(34.39M)(30.95M)
Income Before Tax(10.18M)(23.23M)(55.57M)31.46M56.54M
Pre-Tax Margin-1.4%-3.0%-7.4%4.0%7.1%
Income Tax Expense15.08M9.6M(46.7M)15.07M26.1M
Net Income(25.25M)(32.83M)(8.87M)16.39M30.44M
Net Margin-3.4%-4.3%-1.2%2.1%3.8%
EPS (Basic)(0.06)(0.08)(0.02)0.040.09
EPS (Diluted)(0.06)(0.08)(0.02)0.040.09
Weighted Avg Shares409.98M412.86M410.32M385.74M356.33M
Weighted Avg Shares (Diluted)409.98M412.86M410.32M392.17M356.97M

GoodRx Holdings, Inc.

NASDAQ:GDRX

Intrinsic Alpha fair value

Locked

Current Price

$3.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.